Spex Capital is a London-based investment management firm established in 2021, focusing on the digital health and medical technology sectors. The firm specializes in identifying, supporting, and investing in early-stage ventures that aim to introduce disruptive innovations within global healthcare systems. With a unique partnership with the NHS and connections to a broad international healthcare ecosystem—including embassies, trade bodies, universities, and hospitals—Spex Capital seeks to commercialize and scale promising digital health companies. By leveraging these relationships, the firm aims to source and advance high-quality technologies that can improve healthcare delivery worldwide.
Knokcare is an app-based healthcare platform designed to streamline the connection between patients and medical professionals. It offers a comprehensive solution that includes AI chatbots for self-assessment, video consultations, and in-home doctor visits, all integrated within a single application. This approach enhances patient convenience and improves the efficiency of healthcare systems. The platform also ensures the security of patient records, allowing medical institutions and healthcare providers to deliver effective care. If a patient's condition is deemed serious, Knokcare facilitates a referral to a hospital for further treatment.
Skin Analytics
Series A in 2020
Skin Analytics specializes in developing digital solutions for monitoring skin health, with a primary focus on the early detection of skin cancer. Utilizing patent-pending algorithms and artificial intelligence, the company analyzes smartphone images of skin to track changes in moles and lesions. This technology aids in identifying both skin cancers and precancerous conditions, allowing patients and healthcare professionals to evaluate treatment options effectively. By creating a digital history of an individual's skin, Skin Analytics empowers users to take control of their skin health. The company aims to deliver a range of innovative skin health products over the next few years, catering to both consumer and clinical needs.
Log my Care
Seed Round in 2020
Log my Care is a provider of a free electronic care planning and management system aimed at enhancing coordination and communication within care facilities. The platform replaces traditional paper recording with an electronic system, featuring a shared to-do log that informs care employees of their assigned tasks. Additionally, it offers printable reports on activity performance, allowing managers to maintain oversight of their operations efficiently. This software facilitates better management of care services, ensuring that providers can operate more effectively while delivering quality care to clients.
MediShout
Pre Seed Round in 2020
MediShout Ltd. is a London-based company that develops a digital platform aimed at enhancing operational efficiency within healthcare settings such as hospitals, general practices, and care homes. Established in 2013, the platform connects healthcare teams, suppliers, and various systems, facilitating better communication and workflow among staff. By integrating features like two-way conversations, instant feedback, and artificial intelligence, MediShout addresses inefficiencies in hospital environments, helping to streamline processes and predict future challenges. The technology aims to reduce delays in patient care and optimize resource utilization, allowing healthcare professionals to focus more on patient needs and less on administrative burdens.
Firza
Seed Round in 2020
Firza Ltd specializes in providing tailored support and operational assistance to the healthcare sector, including general practices, community pharmacies, prisons, and care homes. The company offers a comprehensive range of services such as medication reviews, prescription reauthorizations, document management, and out-of-hours support. Additionally, Firza facilitates care home assistance, flexible general practice hours, pharmacist-led clinics, and quality improvement initiatives. Utilizing technology-enabled workforce solutions, Firza incorporates robotic process automation and artificial intelligence to enhance primary healthcare operations. Founded in 2014 and based in London, Firza is committed to delivering practical solutions that cater to the specific needs of healthcare providers, thereby modernizing the delivery of primary health care services across the United Kingdom.
LiveSmart
Seed Round in 2020
LiveSmart U.K. Limited is a health assessment services provider based in London, established in 2016. The company specializes in a comprehensive range of health and wellness assessments, focusing on areas such as cardiovascular health, liver and kidney function, bone health, and mental health. It offers home blood tests, including vitamin D deficiency tests, and provides digital health programs that encompass pathology-based assessments, dietitian and health coach solutions, and educational resources. LiveSmart also supplies blood pressure monitors to help mitigate health risks. Its flagship solution enables employees to monitor and enhance their health, aiming to reduce sickness absence, improve long-term health outcomes, and boost productivity for businesses. The company has adapted to evolving health needs by supplying antibody tests and supporting both small businesses and large corporate clients through its established platform.
LiveSmart
Seed Round in 2019
LiveSmart U.K. Limited is a health assessment services provider based in London, established in 2016. The company specializes in a comprehensive range of health and wellness assessments, focusing on areas such as cardiovascular health, liver and kidney function, bone health, and mental health. It offers home blood tests, including vitamin D deficiency tests, and provides digital health programs that encompass pathology-based assessments, dietitian and health coach solutions, and educational resources. LiveSmart also supplies blood pressure monitors to help mitigate health risks. Its flagship solution enables employees to monitor and enhance their health, aiming to reduce sickness absence, improve long-term health outcomes, and boost productivity for businesses. The company has adapted to evolving health needs by supplying antibody tests and supporting both small businesses and large corporate clients through its established platform.
Skin Analytics
Seed Round in 2019
Skin Analytics specializes in developing digital solutions for monitoring skin health, with a primary focus on the early detection of skin cancer. Utilizing patent-pending algorithms and artificial intelligence, the company analyzes smartphone images of skin to track changes in moles and lesions. This technology aids in identifying both skin cancers and precancerous conditions, allowing patients and healthcare professionals to evaluate treatment options effectively. By creating a digital history of an individual's skin, Skin Analytics empowers users to take control of their skin health. The company aims to deliver a range of innovative skin health products over the next few years, catering to both consumer and clinical needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.